49-Year-Old Woman Presenting for Screening Mammography, Revealing Right Breast Architectural Distortion: (A) Right craniocaudal, (B) mediolateral oblique, (C) spot compression tomosynthesis images show architectural distortion in right breast at 12 o’clock position (arrows). No sonographic correlate identified. Tomosynthesis-guided needle biopsy yielded radial scar—not upgraded at surgery.

February 3, 2022 — According to an article in ARRS’ American Journal of Roentgenology (AJR), imaging surveillance is a management alternative for architectural distortion on digital breast tomosynthesis (DBT) yielding radial scar without atypia and other concordant benign pathologies without atypia at biopsy.

“To our knowledge,” coauthors Juan Villa Camacho and Manisha Bahl of Massachusetts General Hospital in Boston contended, “this investigation represents the largest study of nonmalignant architectural distortion on DBT.”

Defining architectural distortion as parenchymal distortion with no visible mass, Camacho and Bahl’s retrospective study included cases of mammographically detected architectural distortion from July 1, 2016 to June 30, 2019 that were nonmalignant at image-guided needle biopsy and underwent surgical excision. Mammographic examinations included both digital 2D mammography and DBT. With imaging data extracted from radiology reports, upgrade rates were summarized using descriptive statistics.

The overall upgrade rate of architectural distortion on DBT with concordant nonmalignant pathology results at biopsy to malignancy at surgery was 10.2% (13/128). The upgrade rate to malignancy of architectural distortion without atypia at biopsy was 2.2% (2/89) and of architectural distortion with atypia was 28.2% (11/39).

Noting that, historically, surgery has been recommended for all cases of architectural distortion, including cases that are nonmalignant at biopsy, “our results suggest that imaging surveillance rather than surgery may be considered for radial scars without atypia and other benign concordant pathologies without atypia,” the pair concluded.

For more information: www.arrs.org

DBT

Related Breast Imaging Content:

VIDEO: Use of Breast MRI Screening in Women With Dense Breasts — Interview with Christiane Kuhl, M.D.

Abbreviated MRI Outperforms 3-D Mammograms at Finding Cancer in Dense Breasts

VIDEO: Explaining Dense Breasts — Interview with Christiane Kuhl, M.D.

VIDEO: Use of Breast MRI Improved Cancer Detection in Dense Breasts in Dutch Study — Interview with Gillian Newstead, M.D.

Technologies to Watch in Breast Imaging

Screening MRI Detects BI-RADS 3 Breast Cancer in High-risk Patients

Rapid Breast MRI Screening Improves Cancer Detection in Dense Breasts

Breast MRI in Cancer Diagnosis


Related Content

News | Computed Tomography (CT)

July 23, 2026 — HOPPR has introduced HOPPR EF Chest CT Narrative Model, a foundation model that processes 3D chest CT ...

Time July 27, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

July 7, 2026 — Imagion Biosystems, Ltd. recently announced it has renewed and extended its collaboration agreement with ...

Time July 07, 2026
arrow
News | Breast Imaging

July 7, 2026 — QT Imaging Holdings, Inc. recently announced it has successfully completed its first routine inspection ...

Time July 07, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Mammography

June 30, 2026 — The Food and Drug Administration has cleared new contrast-enhanced mammography (CEM) and CEM biopsy ...

Time June 30, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
News | Women's Health

June 2, 2026 — Results of an American College of Radiology-managed retrospective study involving 110,000 women presented ...

Time June 02, 2026
arrow
News

May 21, 2026 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 22, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
News | Women's Health

April 16, 2026 – GE HealthCare has expanded its collaboration with DeepHealth, Inc., a wholly-owned subsidiary of RadNet ...

Time April 20, 2026
arrow
Subscribe Now